ARTICLE | Distillery Therapeutics
UCSF team develops trivalent binder of SARS-CoV-2 spike for COVID-19
October 27, 2020 8:13 PM UTC
DISEASE CATEGORY: Infectious disease
INDICATION: Coronavirus...
BCIQ Company Profiles
DISEASE CATEGORY: Infectious disease
INDICATION: Coronavirus...
BCIQ Company Profiles
BCIQ Company Profiles